PRINCETON, N.J.--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (the “Company”) (NASDAQ: PDGI), a leading provider of clinical development services, today reported a net loss for the first quarter ended March 31, 2008, of $10.1 million, or $0.53 per diluted share, compared to net earnings from continuing operations of $6.0 million, or $0.32 per diluted share, in the first quarter 2007.
